Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs
The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.
The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.
Phone: 03 8561 9000
Abcam knockout cell lines, lysates and pellets
Abcam's knockout (KO) catalogue range and custom service makes it easy for scientists to get...
Echelon Biosciences PIP Mass Assays
Developed by Echelon Biosciences, PIP Mass Assays offer researchers a comprehensive selection of...
Aviva Systems Biology Protein on Demand semi-custom recombinant proteins
Protein on Demand allows users to semi-customise the tag and expression system used to produce...
